Testing effectiveness (Phase 2)Study completedNCT02758223
What this trial is testing
Prophylactic Application of Donor-derived TCM After Allogeneic HSCT
Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Wuerzburg University Hospital 16